Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.37 |
| ▸ | PGR | P06401 | 4/20 | 0.34 |
| ▸ | TDP2 | O95551 | 3/20 | 0.33 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | S100A4 | P26447 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | PNMT | P11086 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1086094 | 0.92 | PDK2 (0.41) | PDK2PGRTDP2AKR1A1AKR1B1 | |
| SCHEMBL29514438 | 0.92 | PDK2 (0.41) | PDK2PGRTDP2AKR1A1AKR1B1 | |
| SCHEMBL429934 | 0.92 | PDK2 (0.45) | PDK2 | |
| SCHEMBL13935036 | 0.89 | L3MBTL1 (0.33) | PDK2NPC1RAB9ASMN1; SMN2GAA | |
| SCHEMBL16358511 | 0.88 | PDK2 (0.33) | PDK2TDP2 | |
| SCHEMBL10018671 | 0.87 | PDK2 (0.38) | PDK2PGRTDP2AKR1A1AKR1B1 | |
| SCHEMBL430152 | 0.87 | PDK2 (0.41) | PDK2 | |
| SCHEMBL14367201 | 0.87 | PDK2 (0.41) | PDK2 | |
| SCHEMBL15774245 | 0.86 | PDK2 (0.35) | PDK2PGRTDP2AKR1A1AKR1B1 | |
| SCHEMBL21808487 | 0.85 | NPC1 (0.46) | NPC1RAB9ASMN1; SMN2GAANFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | OR10J3, LEF1, RPL19 | PDK2 3230/4885PGR 756/4885TDP2 4014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.